GH Research PLC (GHRS) vs Nutex Health, Inc. (NUTX)

A side-by-side comparison of GH Research PLC and Nutex Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — GHRS vs NUTX

growth of $100 · dividends reinvested · last 5y
GHRS +15.2% (+2.9%/yr)NUTX -48.3% (-12.4%/yr)GHRS compounded faster over this window
0200400600Start $10020222023202420252026$115$52
GHRS NUTX

GHRS vs NUTX: by the numbers

  • •NUTX is the larger company ($1.50B vs $1.48B market cap).
  • •NUTX is profitable (21.25% net margin) while GHRS runs a net loss (0.00%).

Metrics side by side

Valuation

MetricGHRSNUTX
P/E ratioN/A8.64
Forward P/EN/A7.86
P/S ratioN/A1.77
P/B ratio4.103.81
EV / EBITDAN/A4.27
FCF yieldN/A18.24%

Profitability

MetricGHRSNUTX
Gross margin0.00%51.26%
Operating margin0.00%31.49%
Net margin0.00%21.25%
ROE-17.32%45.63%
ROIC-19.87%33.76%

Growth (annualized)

MetricGHRSNUTX
Revenue CAGR (5Y)N/A37.66%
EPS CAGR (5Y)N/A-14.73%
Total return CAGR (5Y)0.52%-18.99%

Frequently asked

Is GHRS or NUTX more profitable?
NUTX runs the higher net margin — GHRS at 0.00% versus NUTX at 21.25%.
How have GHRS and NUTX total returns compared?
Over the past 5 years, GHRS delivered 0.52% and NUTX delivered -18.99% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.